Both medications work by mimicking hormones your gut releases after you eat, which tell your brain you are full and slow how fast your stomach empties. Semaglutide copies one of those hormones, called GLP-1 (glucagon-like peptide-1). When GLP-1 levels stay high, you feel satisfied on smaller meals, your cravings quiet down, and your body manages blood sugar more steadily.
Tirzepatide copies that same GLP-1 hormone and adds a second one called GIP (glucose-dependent insulinotropic polypeptide). GIP works alongside GLP-1 to sharpen how your body handles blood sugar and fat, and the two hormones together tend to blunt appetite more than GLP-1 alone. Researchers call tirzepatide a dual agonist because it hits both targets.
That second pathway is why tirzepatide often produces larger weight loss in clinical trials. You are pressing two appetite and metabolism levers instead of one, so the combined effect on how much you eat and how your body stores energy is stronger. The difference is real, but it does not make semaglutide a weak option. Many people reach their goals on GLP-1 alone, and a lower dose or milder response can be the better fit depending on how your body reacts.
Here is how the two medications stack up side by side. Use this as your quick reference, then read on for the trial data and tolerability details behind each row.
Semaglutide
Tirzepatide
Mechanism
GLP-1 only (single hormone)
GLP-1 + GIP (dual hormone)
Trial-average weight loss
13.7% of body weight (about 33.1 lbs) in SURMOUNT-5
20.2% of body weight (about 50.3 lbs) in SURMOUNT-5
Common side effects
Nausea, constipation, reflux, usually early and fading
Similar profile, sometimes stronger appetite suppression
Optima pricing
$249 for 10 weeks, all-inclusive
$499 for 10 weeks, all-inclusive
Best for
Steady, proven weight loss at a lower price point
The largest average reduction, if the cost fits your goals
Both use the same active ingredients as the FDA-approved brand-name drugs, but Optima's compounded versions are prepared by licensed pharmacies and are not themselves FDA-approved.
Both medications earned their reputations through large, well-run clinical trials, and the numbers give you a fair basis for comparison. The most useful data comes from four sources. Two trials tested each drug on its own, one trial put them head-to-head, and a 2025 meta-analysis pooled results across studies.
The STEP 1 trial established what semaglutide can do for weight loss. Published in the New England Journal of Medicine in 2021, the trial followed adults with obesity for 68 weeks on weekly semaglutide alongside lifestyle changes. Participants lost an average of 14.9% of their body weight, compared with 2.4% for those on placebo. Those results moved semaglutide from a diabetes medication into a genuine obesity treatment.
SURMOUNT-1 tested tirzepatide the same way and produced larger numbers. Published in the New England Journal of Medicine in 2022, the trial ran 72 weeks in adults with obesity who did not have diabetes. At the highest dose, participants lost an average of 20.9% of their body weight. That figure hinted at a real gap between the two drugs, but comparing across separate trials is imperfect because the patient groups and study designs differ.
SURMOUNT-5 removed that guesswork by putting both drugs in the same trial. The study assigned adults with obesity to either weekly tirzepatide or weekly semaglutide and followed them for 72 weeks. Tirzepatide produced an average weight loss of 20.2%, roughly 50.3 pounds, while semaglutide produced 13.7%, roughly 33.1 pounds. Because both groups followed the same protocol, that 6.5-point difference reflects the medications themselves rather than differences in study setup.
A 2025 meta-analysis reinforced the same pattern across the broader research. By combining results from multiple trials, the analysis found tirzepatide consistently outperformed semaglutide on average weight loss, which matches what SURMOUNT-5 showed directly. Pooled analyses matter because a single trial can produce an outlier result. When many studies point the same direction, you can trust the finding more.
The clear takeaway is that tirzepatide tends to produce more weight loss on average, and the head-to-head data backs that up. That average does not decide your outcome. Some people respond exceptionally well to semaglutide, and factors like tolerability, cost, and how your body reacts often matter more than a trial average. A provider who reviews your history can help you weigh the evidence against your own goals.
The compounded semaglutide and tirzepatide Optima prepares contain the same active ingredients studied in these trials. The compounded versions themselves are prepared by licensed pharmacies and are not FDA-approved, so the trial results describe the brand-name medications rather than a direct study of the compounded formulations.
Both semaglutide and tirzepatide share the same core side effects because they act on the same gut and appetite pathways. The most common complaints are nausea, constipation, diarrhea, and occasional vomiting, especially in the first few weeks after a dose increase. These effects come from the way GLP-1 medications slow how fast your stomach empties, which is also part of why they help you feel full. For most people, the nausea fades as the body adjusts.
Tirzepatide adds a second hormone signal, GIP, and that extra mechanism does not automatically mean worse side effects. In the SURMOUNT trials, the tolerability profile looked broadly similar to semaglutide, with gastrointestinal complaints leading the list on both drugs. A minority of patients on either medication stopped treatment because of side effects, and the rates were close between the two.
Where the two differ comes down to individual response rather than a clear winner. Some people tolerate tirzepatide better despite its stronger weight-loss effect, while others do fine on semaglutide and see no reason to switch. Because tirzepatide often drives faster weight loss, a few patients notice more pronounced early nausea if the dose climbs too quickly, which is why gradual titration matters.
Slow, guided dose increases are the single best tool for keeping side effects manageable on either medication. Starting low and stepping up over weeks gives your gut time to adapt, and most people who quit early do so because the dose rose faster than their body was ready for. At Optima, your provider adjusts your schedule based on how you actually feel, and your customized dosing chart lays out each week so you are never guessing. If a side effect becomes hard to manage, you reach the same clinician who started your care, not a call center.
Both medications follow a slow, stepped increase in dose, and that gradual ramp is what keeps side effects manageable. You inject once a week under the skin, usually in your abdomen, thigh, or upper arm. Starting low and building up over several weeks gives your stomach time to adjust, which is why rushing to a higher dose tends to cause more nausea, not faster results.
Semaglutide typically starts around 0.25 mg per week and climbs in stages toward a maintenance dose over a few months. Tirzepatide begins near 2.5 mg per week and steps up on a similar schedule. Your provider sets the pace based on how you tolerate each level, so the exact timeline is yours rather than a fixed formula.
The weekly rhythm matters more than most people expect. A steady dose keeps the medication working consistently in your system, and skipping or spacing out injections tends to bring back appetite and stall progress. Picking one day a week and sticking to it is the simplest way to stay on track.
At Optima, your program is vial-based rather than a monthly subscription, and you receive a customized PDF dosing chart that spells out your weekly units. That chart takes the guesswork out of drawing the right amount, and the same nurse practitioners who start you guide any dose changes along the way. You are never adjusting on your own or wondering whether you got the dose right.
Semaglutide and tirzepatide share overlapping medical uses, but their approved indications differ in important ways. Both compounds treat type 2 diabetes by helping the body regulate blood sugar, and both help with chronic weight management. The brand-name versions carry specific FDA approvals, while the compounded medications Optima provides use the same active ingredients prepared by licensed pharmacies. The compounded versions are not themselves FDA-approved.
Semaglutide's active ingredient is FDA-approved under two brand names. Ozempic treats type 2 diabetes, and Wegovy treats chronic weight management in adults with obesity or overweight who have a related health condition. In 2024, the FDA also cleared semaglutide to reduce the risk of heart attack and stroke in adults with cardiovascular disease and obesity, which broadens its role beyond weight and blood sugar alone.
Tirzepatide's active ingredient carries a parallel set of approvals. Mounjaro treats type 2 diabetes, and Zepbound treats chronic weight management. In late 2024, the FDA approved Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity, making it the first medication cleared for that condition. Tirzepatide's dual action on both GLP-1 and GIP receptors is part of why it produces larger effects across these areas.
For most people considering either option through Optima, the practical question is weight loss and metabolic health rather than a specific diagnosis. A licensed nurse practitioner reviews your history, current medications, and goals to determine which medication fits you, and whether either is appropriate for your situation.
At Optima, semaglutide runs $249 for 10 weeks and tirzepatide runs $499 for 10 weeks, and both prices cover everything you need to start. That flat rate includes the medication, the supplies, your consultation with a licensed nurse practitioner, and shipping to your door. You pay what you see. There are no membership fees, contracts, or surprise charges layered on later.
These are fixed-duration, vial-based programs, not monthly subscriptions. You pay for the medication your body needs, and your provider's dosing plan determines how long each vial lasts. Along with the medication, you receive a customized PDF dosing chart that shows your weekly units, so you always know exactly how much to draw and when.
One honest note on the medications themselves. Optima's semaglutide and tirzepatide are compounded by licensed pharmacies. The active ingredients are the same as the FDA-approved brand-name versions, but the compounded preparations are not themselves FDA-approved. A licensed provider oversees your care from the first consult through follow-up, so you have a real clinician guiding the plan rather than an app or a call center.
The $250 gap between the two programs reflects the difference in what each medication does. Tirzepatide works through two hormone pathways instead of one, and clinical trials show it produces larger average weight loss. Semaglutide costs less and still delivers strong results for many people, which makes it a sensible starting point if you want to see how your body responds before committing to the higher-priced option.
Optima is proudly local in Tyler, Texas, with statewide telehealth and discreet home delivery across the state. You can start online from anywhere in Texas or visit the Tyler clinic in person, and the same providers stay with you throughout.
The right medication depends on how much weight you want to lose, how your body tolerates GLP-1 drugs, and what you can spend. Both semaglutide and tirzepatide work well. The choice comes down to matching one to your situation, which is exactly what your provider helps you do during a consultation.
Start with tirzepatide if your goal is maximum weight loss. The SURMOUNT-5 head-to-head trial showed tirzepatide patients lost an average of 20.2% of body weight versus 13.7% on semaglutide. If you have a larger amount to lose or you have tried semaglutide and stalled, the dual GLP-1 and GIP action gives you more room to work with. The tradeoff is cost, at $499 for 10 weeks versus $249.
Start with semaglutide if cost matters most or you have moderate goals. At $249 for 10 weeks, semaglutide is the more accessible entry point, and STEP 1 trial data confirms it produces real, clinically meaningful weight loss. For someone who wants to lose 20 to 40 pounds without stretching the budget, semaglutide is a sound first choice.
Choose based on tolerability if you have a sensitive stomach. Both medications cause nausea and other digestive side effects, usually early and usually fading as your dose ramps up slowly. Some people handle one better than the other, and there is no way to predict which in advance. Your provider adjusts dosing week to week, and switching between the two is straightforward if the first choice does not sit well.
Consider your history with GLP-1s. If you have already run a full semaglutide course and want more progress, moving to tirzepatide often makes sense. If you are brand new to this class of medication, either one is a reasonable place to begin, and starting lower and adjusting up keeps side effects manageable.
None of these paths is one-size-fits-all, and the medications are compounded versions prepared by licensed pharmacies, not the FDA-approved brand names. A licensed Optima nurse practitioner reviews your history, weighs these factors with you, and builds a customized dosing plan for whichever medication fits.
Optima runs both programs as fixed-duration, vial-based treatments, not monthly subscriptions. Semaglutide costs $249 for 10 weeks, and tirzepatide costs $499 for 10 weeks. Both prices include the medication, injection supplies, your consultation, and shipping. You pay one flat amount, and no membership fee, contract, or surprise charge shows up later.
The active ingredients in Optima's compounded semaglutide and tirzepatide match the ones in the FDA-approved brand-name medications. The compounded versions themselves are prepared by licensed pharmacies and are not FDA-approved. Optima is LegitScript certified, and licensed nurse practitioners own and run the practice, so you work with the same provider from your first consult through follow-up.
Every weight-loss patient receives a customized dosing chart as a PDF, laying out the exact number of units to inject each week. Your provider sets that schedule based on how your body responds, and how long each vial lasts follows from that guided dosing. If side effects show up or progress stalls, the same clinician adjusts your plan rather than routing you to a call center.
Optima is locally owned in Tyler, Texas, and treats patients across the state through telehealth. You can start entirely online with discreet home delivery, or you can visit the Tyler clinic in person when you prefer face-to-face care. Many national programs offer flat pricing and certification too, so what sets Optima apart is the combination of a real East Texas clinic, a consistent named provider, and both GLP-1 weight loss and TRT handled under one roof.
If you already know tirzepatide's stronger trial results justify the higher cost, you can begin there. If you want to see how you tolerate a GLP-1 first, semaglutide is a reasonable starting point, and your provider can help you weigh the tradeoff during the consultation.
In the SURMOUNT-5 head-to-head trial, tirzepatide produced greater average weight loss than semaglutide, at 20.2% versus 13.7% of body weight. Both medications work well, and Optima offers each so your provider can match the choice to your goals, budget, and how your body responds. Tirzepatide adds a second hormone target, which explains part of the larger average result.
Semaglutide acts on one gut hormone receptor called GLP-1, which slows digestion and reduces appetite. Tirzepatide acts on GLP-1 plus a second hormone called GIP, and this dual action tends to blunt hunger more. At Optima, both come as vial-based programs with a customized weekly dosing chart, so you know exactly how much to use.
Both medications share the same common side effects, mostly nausea, constipation, and other digestive complaints that usually ease as your dose rises slowly. Neither drug clearly wins on tolerability, and your experience depends on your body and how carefully the dose is titrated. Your Optima provider adjusts the plan if side effects become hard to manage.
The active ingredients match those in FDA-approved brand-name medications, but the compounded versions Optima dispenses are prepared by licensed pharmacies and are not themselves FDA-approved. A licensed nurse practitioner reviews your case and oversees your care from consult through follow-up. Optima is LegitScript certified, so you can verify the practice meets health and safety standards.
Semaglutide runs $249 for 10 weeks, and tirzepatide runs $499 for 10 weeks, with medication, supplies, consultation, and shipping included in that flat price. There is no subscription, membership, or contract, and no hidden fees. You pay for the medication your body needs, and provider-guided dosing determines how long each vial lasts.
Yes, and many people start on semaglutide and later move to tirzepatide if their results plateau or their goals change. Your Optima provider guides any switch and adjusts your dosing chart so the transition stays comfortable. Because both run as fixed-duration programs, you can reassess at the end of each cycle rather than lock into a long commitment.
The right medication depends on your body, your history, and your goals, and that decision is easier with a provider who knows your full picture. At Optima, licensed nurse practitioners own and run the practice, so the same clinician guides you from your first consult through every follow-up. You book a consultation, talk through whether semaglutide or tirzepatide fits you, and get a customized dosing chart if you move forward.
Pricing stays flat and all-inclusive. Semaglutide runs $249 for 10 weeks, and tirzepatide runs $499 for 10 weeks, with medication, supplies, consultation, and shipping covered. No memberships, no hidden fees.
We're proudly local in Tyler, Texas, with in-person care available and discreet home delivery across the state. Book your consultation and let's find the right fit together. Less weight. More life.